The purpose here was to correlate the immunohistochemical expression of cyclin D1, CDK4 and p16 with the main clinical prognostic factors for breast cancer: tumor stage, nodal status, tumor grade, steroid receptors (ER and PR), HER2 status and proliferation rate. This evidence concerns the gene ESR1 and breast carcinoma.